Jiangsu Hengrui Medicine
600276.SS
$6.29
Share price
2.96%
Change (1 day)
-9.63%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.37 B
According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are $0.37 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.57 B | -1.42% |
| 2021-12-31 | $0.57 B | -4.09% |
| 2020-12-31 | $0.60 B | 61.24% |
| 2019-12-31 | $0.37 B | -0.32% |
| 2018-12-31 | $0.37 B | 16.73% |
| 2017-12-31 | $0.32 B | 53.7% |
| 2016-12-31 | $0.20 B | 19.29% |
| 2015-12-31 | $0.17 B | 16.62% |
| 2014-12-31 | $0.15 B | 61.57% |
| 2013-12-31 | $93.26 M | 29.21% |
| 2012-12-31 | $72.17 M | 3.22% |
| 2011-12-31 | $69.92 M | 9.88% |
| 2010-12-31 | $63.63 M | 30.2% |
| 2009-12-31 | $48.87 M | 44.84% |
| 2008-12-31 | $33.74 M | -38.86% |
| 2007-12-31 | $55.19 M | 114.26% |
| 2006-12-31 | $25.75 M | 17.35% |
| 2005-12-31 | $21.95 M | -29.48% |
| 2004-12-31 | $31.12 M | -52.98% |
| 2003-12-31 | $66.2 M | 38.88% |
| 2002-12-31 | $47.67 M | 9.29% |
| 2001-12-31 | $43.62 M |